New approaches to the prevention of atherosclerosis
- PMID: 8521767
- DOI: 10.2165/00003495-199550030-00003
New approaches to the prevention of atherosclerosis
Abstract
In recent years, remarkable progress has been made in the prevention and treatment of atherosclerosis. However, much of the research has been devoted to the investigation of lipid metabolism and lipid-lowering drugs. This review highlights some recent topics in both experimental and clinical investigations, with emphasis on studies other than those on lipid-lowering drugs. These topics include oxidative modification of lipoproteins, hyperfibrinogenaemia, hyperhomocysteinaemia, female sex hormones and endothelium-derived relaxing factor (or nitric oxide). Some of these approaches have already been applied in the clinic.
Similar articles
-
Current, new and future treatments in dyslipidaemia and atherosclerosis.Drugs. 2000 Jul;60(1):55-93. doi: 10.2165/00003495-200060010-00005. Drugs. 2000. PMID: 10929930 Review.
-
Influence of sex and sex hormones upon the development of atherosclerosis and upon the lipoproteins of plasma.J Chronic Dis. 1955 Jan;1(1):63-85. doi: 10.1016/0021-9681(55)90022-9. J Chronic Dis. 1955. PMID: 13233312 No abstract available.
-
Lipid-lowering agents and their meaning in the treatment of the fat metabolism-atherosclerosis functional circle.Int J Clin Pharmacol Ther Toxicol. 1981 Jul;19(7):289-96. Int J Clin Pharmacol Ther Toxicol. 1981. PMID: 7263106
-
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice.J Clin Invest. 2002 Feb;109(4):541-8. doi: 10.1172/JCI14066. J Clin Invest. 2002. PMID: 11854327 Free PMC article.
-
Therapeutic strategies for coronary artery disease beyond low density lipoprotein (LDL)--lowering.Curr Pharm Des. 1999 Jan;5(1):1-10. Curr Pharm Des. 1999. PMID: 10066880 Review.
Cited by
-
Hyperhomocysteinemia and cardiovascular disease: The nutritional perspectives.Indian J Clin Biochem. 2000 Aug;15(Suppl 1):20-30. doi: 10.1007/BF02867541. Indian J Clin Biochem. 2000. PMID: 23105265 Free PMC article.
-
Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.Drugs. 2002;62(13):1909-44. doi: 10.2165/00003495-200262130-00013. Drugs. 2002. PMID: 12215067 Review.
-
HMG-CoA reductase inhibitors and myotoxicity.Drug Saf. 2000 Jun;22(6):441-57. doi: 10.2165/00002018-200022060-00003. Drug Saf. 2000. PMID: 10877038 Review.
-
Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.Drugs. 1997 Oct;54(4):615-33. doi: 10.2165/00003495-199754040-00007. Drugs. 1997. PMID: 9339964 Review.
-
Effects of gender and gonadectomy on growth and plasma cholesterol levels in pigs.Nutr Res Pract. 2009 Spring;3(1):38-42. doi: 10.4162/nrp.2009.3.1.38. Epub 2009 Mar 31. Nutr Res Pract. 2009. PMID: 20016700 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources